Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

rebel distributors corp - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. abuse of and/or dependence on dicyclomine for anticholinergic effects have been rarely reported.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

life line home care services, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 20 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

state of florida doh central pharmacy - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride 10 mg - for the treatment of functional bowel/irritable bowel syndrome. - obstructive uropathy obstructive uropathy - obstructive disease of the gastrointestinal tract obstructive disease of the gastrointestinal tract - severe ulcerative colitis (see precautions) severe ulcerative colitis (see precautions) - reflux esophagitis reflux esophagitis - unstable cardiovascular status in acute hemorrhage unstable cardiovascular status in acute hemorrhage - glaucoma glaucoma - myasthenia gravis myasthenia gravis - evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations evidence of prior hypersensitivity to dicyclomine hydrochloride or other ingredients of these formulations - infants less than 6 months of age (see warnings and precautions: information for patients.) infants less than 6 months of age (see warnings and precautions: information for patients.) - nursing mothers (see warnings and precautions: information for patients). nursing mothers (see war

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - verapamil hydrochloride -

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

bryant ranch prepack - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 360 mg - verapamil hydrochloride sustained-release capsules are indicated for the management of essential hypertension. verapamil hcl is contraindicated in: - severe left ventricular dysfunction. (see warnings. ) - hypotension (less than 90 mm hg systolic pressure) or cardiogenic shock. - sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker). - second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). - patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g., wolff-parkinson-white, lown-ganong-levine syndromes). (see warnings. ) - patients with known hypersensitivity to erapamil hydrochloride.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 100 mg - verapamil hydrochloride extended-release capsules (pm) for oral use are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a va

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

physicians total care, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 100 mg - verapamil hydrochloride extended-release capsules (pm) for oral use are indicated for the management of essential hypertension. verapamil is contraindicated in: - severe left ventricular dysfunction [see warnings and precautions (5.1)] . - hypotension (less than 90 mm hg systolic pressure) or cardiogenic shock. - sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker). - second- or third-degree av block (except in patients with a functioning artificial ventricular pacemaker). - patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g.,  wolff-parkinson-white, lown-ganong-levine syndromes) [see warnings and precautions (5.4)]. reproduction studies have been performed in rabbits and rats at oral doses up to 1.9 (15 mg/kg/day) and 7.5 (60 mg/kg/day) times the human oral daily dose, respectively, and have revealed no evidence of teratogenicity. in the rat, however, this multiple of the human dose was embryocidal and retarded fetal growth and devel

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

remedyrepack inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride capsules, usp are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific p opu l a ti on s (8.4) ] , nursing mothers [see use in specific populations (8.3)] and in patients with: •     unstable cardiovascular status in acute hemorrhage •     myasthenia gravis [see warnings and precautions (5.4)] •     glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] •     obstructive uropathy [see warnings and precautions (5.8)] •     obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] •     severe ulcerative colitis [see warnings and precautions (5.7)] •     reflux

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

bryant ranch prepack - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride capsules, usp are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific p opu l a ti on s (8.4) ] , nursing mothers [see use in specific populations (8.3)] and in patients with: •     unstable cardiovascular status in acute hemorrhage •     myasthenia gravis [see warnings and precautions (5.4)] •     glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] •     obstructive uropathy [see warnings and precautions (5.8)] •     obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] •     severe ulcerative colitis [see warnings and precautions (5.7)] •     reflux esophagitis p r e g n a n c y category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80 to 160 mg/day. however, epidemiologic studies did not show a

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

redpharm drug, inc. - dicyclomine hydrochloride (unii: cq903kqa31) (dicyclomine - unii:4kv4x8if6v) - dicyclomine hydrochloride capsules, usp are indicated for the treatment of patients with functional bowel/irritable bowel syndrome. dicyclomine hydrochloride is contraindicated in infants less than 6 months of age [see use in specific p opu l a ti on s (8.4) ] , nursing mothers [see use in specific populations (8.3)] and in patients with: • unstable cardiovascular status in acute hemorrhage • myasthenia gravis [see warnings and precautions (5.4)] • glaucoma [see adverse reactions (6.3) and drug interactions (7.1)] • obstructive uropathy [see warnings and precautions (5.8)] • obstructive disease of the gastrointestinal tract [see warnings and precautions (5.5)] • severe ulcerative colitis [see warnings and precautions (5.7)] • reflux esophagitis p r e g n a n c y category b adequate and well-controlled studies have not been conducted with dicyclomine hydrochloride in pregnant women at the recommended doses of 80